- ICH GCP
- US Clinical Trials Registry
- Researchers
- Canada
- Fallopian Tube Cancer
Medical specialists from Canada tagged as investigators in clinical trials studying Fallopian Tube Cancer
Total 30 results
-
Alannah Smrke, MDSeen in:
- British Columbia, Vancouver, BC Cancer - Vancouver
Trials:- NCT05445778 (Principal Investigator)
Conditions: -
Amit OzaSeen in:
- Ontario, Toronto, Princess Margaret
- Ontario, Toronto, Princess Margaret Cancer Centre
- Ontario, Toronto, Princess Margaret Cancer Centre - University Health Network
- Ontario, Toronto, Princess Margaret Hospital
- Ontario, Toronto, University Health Network - Princess Margaret Hospital
- Ontario, Toronto, University Health Network, Princess Margaret Hospital
- Ontario, Toronto, University health Network (UHN)-University of Toronto
- Toronto, Princess Margaret Cancer Center
- Toronto, Princess Margaret Cancer Centre
Trials:- NCT05483933 (Principal Investigator)
- NCT04260802 (Principal Investigator)
- NCT05041257 (Principal Investigator)
- NCT05611931 (Principal Investigator)
- NCT02632448 (Principal Investigator)
- NCT05445778 (Principal Investigator)
- NCT03029403 (Principal Investigator)
- NCT04625270 (Principal Investigator)
- NCT05229900 (Principal Investigator)
- NCT04159155 (Principal Investigator)
- NCT02334761 (Principal Investigator)
- NCT05870748 (Principal Investigator)
- NCT06003231 (Principal Investigator)
Conditions:- Ovarian Cancer;
- Fallopian Tube Cancer;
- Epithelial Ovarian Cancer;
- Platinum-resistant Ovarian Cancer;
- Primary Peritoneal Carcinoma;
- Platinum-Resistant Fallopian Tube Carcinoma;
- Platinum-Resistant Primary Peritoneal Carcinoma;
- Sarcoma;
- Neoplasms;
- Renal Cell Carcinoma;
- Cervical Cancer;
- Cancer;
- Hepatocellular Carcinoma;
- Gastric Cancer;
- Non Small Cell Lung Cancer;
- Metastatic Cancer;
- Squamous Cell Carcinoma of Head and Neck;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Urothelial Carcinoma;
- Merkel Cell Carcinoma;
- Squamous Cell Carcinoma;
- Locally Advanced Malignant Neoplasm;
- Locally Advanced Solid Tumor;
- Urothelial Neoplasm;
- Peritoneal Cancer;
- Endometrial Cancer;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Rectal Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer;
- Advanced Cancer;
- Low Grade Ovarian Serous Adenocarcinoma;
- Uterine Cervical Neoplasms;
- Stomach Neoplasms;
- Testicular Neoplasms;
- Carcinoma, Non-Small-Cell Lung;
- Ovarian Neoplasms;
- Endometrial Neoplasms;
- Gastroesophageal Junction Carcinoma;
- Endometrial Carcinoma;
- P53 Mutation;
- Serous Carcinoma;
- Pathology;
- Primary Peritoneal Cancer;
- Carcinoma, Squamous Cell of Head and Neck
-
Andrew Robinson, MDSeen in:
- Ontario, Kingston, Kinston Health Sciences Center - KGH Site
Trials:- NCT05445778 (Principal Investigator)
Conditions: -
Anna TinkerSeen in:
- British Columbia, Vancouver, BC Cancer Vancouver
Trials:- NCT05456685 (Principal Investigator)
-
Brent JimSeen in:
- Saskatchewan, Regina, Allan Blair Cancer Centre
Trials:- NCT04095364 (Principal Investigator)
Conditions:- Stage III Fallopian Tube Cancer AJCC v8;
- Stage III Ovarian Cancer AJCC v8;
- Stage III Primary Peritoneal Cancer AJCC v8;
- Stage IV Fallopian Tube Cancer AJCC v8;
- Stage IV Ovarian Cancer AJCC v8;
- Stage IV Primary Peritoneal Cancer AJCC v8;
- Stage II Fallopian Tube Cancer AJCC v8;
- Stage II Ovarian Cancer AJCC v8;
- Stage II Primary Peritoneal Cancer AJCC v8;
- Low Grade Fallopian Tube Serous Adenocarcinoma;
- Ovarian Low Grade Serous Adenocarcinoma;
- Primary Peritoneal Low Grade Serous Adenocarcinoma
-
Diane M. ProvencherSeen in:
- Quebec, Montreal, CHUM - Centre Hospitalier de l'Universite de Montreal
Trials:- NCT04095364 (Principal Investigator)
Conditions:- Stage III Fallopian Tube Cancer AJCC v8;
- Stage III Ovarian Cancer AJCC v8;
- Stage III Primary Peritoneal Cancer AJCC v8;
- Stage IV Fallopian Tube Cancer AJCC v8;
- Stage IV Ovarian Cancer AJCC v8;
- Stage IV Primary Peritoneal Cancer AJCC v8;
- Stage II Fallopian Tube Cancer AJCC v8;
- Stage II Ovarian Cancer AJCC v8;
- Stage II Primary Peritoneal Cancer AJCC v8;
- Low Grade Fallopian Tube Serous Adenocarcinoma;
- Ovarian Low Grade Serous Adenocarcinoma;
- Primary Peritoneal Low Grade Serous Adenocarcinoma
-
Diane ProvencherSeen in:
- Montréal, CHUM
- Montréal, Centre de recherche di Centre Hospitalier de i'Universite de Montreal
- Quebec, Montreal, CHUM
- Quebec, Montreal, Centre Hospitalier de L'Universite de Montreal - Centre de Recherche
- Quebec, Montréal, CHUM - Centre Hospitalier de l'Universite de Montreal
- Quebec, Montréal, CHUM - University of Montreal Hospital Centre
- Quebec, Montréal, Centre Hospitalier de l'Université de Montréal
- Quebec, Montréal, Centre hospitalier de l'Université de Montréal (CHUM)
- Quebec, Montréal, GSK Investigational Site
Trials:- NCT05456685 (Principal Investigator)
- NCT04260802 (Principal Investigator)
- NCT05329545 (Principal Investigator)
- NCT02632448 (Principal Investigator)
- NCT06431594 (Principal Investigator)
- NCT03393884 (Principal Investigator)
- NCT05358639 (Principal Investigator)
- NCT04625270 (Principal Investigator)
- NCT05445778 (Principal Investigator)
- NCT04706962 (Principal Investigator)
- NCT05243524 (Principal Investigator)
Conditions:- Fallopian Tube Cancer;
- Primary Peritoneal Cancer;
- High Grade Ovarian Cancer;
- Sarcoma;
- Neoplasms;
- Renal Cell Carcinoma;
- Cervical Cancer;
- Cancer;
- Hepatocellular Carcinoma;
- Gastric Cancer;
- Ovarian Cancer;
- Non Small Cell Lung Cancer;
- Metastatic Cancer;
- Squamous Cell Carcinoma of Head and Neck;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Urothelial Carcinoma;
- Merkel Cell Carcinoma;
- Squamous Cell Carcinoma;
- Locally Advanced Malignant Neoplasm;
- Locally Advanced Solid Tumor;
- Urothelial Neoplasm;
- High Grade Serous Ovarian Cancer;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Rectal Cancer;
- Endometrial Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer;
- Epithelial Ovarian Cancer;
- High Grade Serous Carcinoma;
- Low Grade Ovarian Serous Adenocarcinoma;
- Peritoneal Cancer;
- Solid Tumor;
- Prostate Cancer;
- Small-cell Lung Cancer;
- Thyroid Cancer;
- Cutaneous Melanoma;
- TNBC - Triple-Negative Breast Cancer;
- Hormone Receptor-positive Breast Cancer;
- SORT1+ Cancers;
- Platinum-resistant Epithelial Ovarian Cancer
-
Dr. Alannah SmrkeSeen in:
- British Columbia, Vancouver, BC Cancer - Vancouver
Trials:- NCT05445778 (Principal Investigator)
Conditions: -
Jennifer Rauw, MDSeen in:
- Alberta, Edmonton, University of Alberta - Cross Cancer Institute (CCI)
Trials:- NCT05445778 (Principal Investigator)
Conditions: -
Johanne Weberpals, MDSeen in:
- Ontario, Ottawa, The Ottawa Hospital Cancer Centre
Trials:- NCT05445778 (Principal Investigator)
Conditions: -
Lara DE GUERKESeen in:
- Montréal, CIUSSS de l'Est-de-I'lle-de-Montreal Hopital Maisonneuve-Rosemont (CAHA)
- Quebec, Montreal, Universite de Montreal - Hopital Maisonneuve-Rosemont (HMR)
Trials:- NCT03386734 (Principal Investigator)
- NCT05445778 (Principal Investigator)
Conditions: -
Lara deGuerke, MDSeen in:
- Quebec, Montreal, Universite de Montreal - Hopital Maisonneuve-Rosemont (HMR)
Trials:- NCT05445778 (Principal Investigator)
Conditions: -
Lilian T. GienSeen in:
- Ontario, Toronto, Odette Cancer Centre- Sunnybrook Health Sciences Centre
Trials:- NCT04095364 (Principal Investigator)
Conditions:- Stage III Fallopian Tube Cancer AJCC v8;
- Stage III Ovarian Cancer AJCC v8;
- Stage III Primary Peritoneal Cancer AJCC v8;
- Stage IV Fallopian Tube Cancer AJCC v8;
- Stage IV Ovarian Cancer AJCC v8;
- Stage IV Primary Peritoneal Cancer AJCC v8;
- Stage II Fallopian Tube Cancer AJCC v8;
- Stage II Ovarian Cancer AJCC v8;
- Stage II Primary Peritoneal Cancer AJCC v8;
- Low Grade Fallopian Tube Serous Adenocarcinoma;
- Ovarian Low Grade Serous Adenocarcinoma;
- Primary Peritoneal Low Grade Serous Adenocarcinoma
-
Lucy GilbertSeen in:
- Quebec, Montreal, McGill University Department of Oncology / McGill University Health Centre
- Quebec, Montreal, McGill University Health Centre
- Quebec, Montréal, McGill University Health Care
- Quebec, Montréal, McGill University Health Centere (MUHC)-Glen Site
- Quebec, Montréal, McGill University Health Centre
- Quebec, Montréal, McGill University Health Centre (MUHC)
Trials:- NCT05456685 (Principal Investigator)
- NCT05611931 (Principal Investigator)
- NCT02632448 (Principal Investigator)
- NCT06003231 (Principal Investigator)
- NCT05483933 (Principal Investigator)
- NCT05445778 (Principal Investigator)
- NCT05870748 (Principal Investigator)
Conditions:- Fallopian Tube Cancer;
- Primary Peritoneal Cancer;
- High Grade Ovarian Cancer;
- Endometrial Cancer;
- Neoplasms;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Ovarian Cancer;
- Rectal Cancer;
- Triple Negative Breast Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer;
- Carcinoma, Non-Small-Cell Lung;
- Ovarian Neoplasms;
- Endometrial Neoplasms;
- Carcinoma, Squamous Cell of Head and Neck;
- Epithelial Ovarian Cancer;
- Platinum-resistant Ovarian Cancer;
- Primary Peritoneal Carcinoma;
- Platinum-Resistant Fallopian Tube Carcinoma;
- Platinum-Resistant Primary Peritoneal Carcinoma;
- Peritoneal Cancer
-
Nidhi Kumar-Tyagi, Dr.Seen in:
- Ontario, Hamilton, Juravinski Cancer Centre
Trials:- NCT05445778 (Principal Investigator)
Conditions: -
Paul BessetteSeen in:
- Quebec, Sherbrooke, CHUS - Hôpital Fleurimont
- Quebec, Sherbrooke, Ciussse-Chus
- Sherbrooke, Quebec, Sherbrooke University Hospital Centre
Trials:- NCT05456685 (Principal Investigator)
- NCT05041257 (Principal Investigator)
- NCT05329545 (Principal Investigator)
- NCT05445778 (Principal Investigator)
-
Prafull Ghatage, MDSeen in:
- Alberta, Calgary, Tom Baker Cancer Centre, Alberta Health Services
Trials:- NCT05445778 (Principal Investigator)
Conditions: -
Stephanie Lheureux, M.D.Seen in:
- Ontario, Toronto, Princess Margaret Cancer Centre
Trials:- NCT04510584 (Principal Investigator)
-
Suzanne FortinSeen in:
- Quebec, Montréal, CIUSSS de l'IIe-de-Montreal
Trials:- NCT05456685 (Principal Investigator)
-
Taymaa MaySeen in:
- Ontario, Toronto, University Health Network-Princess Margaret Hospital
Trials:- NCT04095364 (Principal Investigator)
Conditions:- Stage III Fallopian Tube Cancer AJCC v8;
- Stage III Ovarian Cancer AJCC v8;
- Stage III Primary Peritoneal Cancer AJCC v8;
- Stage IV Fallopian Tube Cancer AJCC v8;
- Stage IV Ovarian Cancer AJCC v8;
- Stage IV Primary Peritoneal Cancer AJCC v8;
- Stage II Fallopian Tube Cancer AJCC v8;
- Stage II Ovarian Cancer AJCC v8;
- Stage II Primary Peritoneal Cancer AJCC v8;
- Low Grade Fallopian Tube Serous Adenocarcinoma;
- Ovarian Low Grade Serous Adenocarcinoma;
- Primary Peritoneal Low Grade Serous Adenocarcinoma
-
Vickie J. MartinSeen in:
- Saskatchewan, Saskatoon, Saskatoon Cancer Centre
Trials:- NCT04095364 (Principal Investigator)
Conditions:- Stage III Fallopian Tube Cancer AJCC v8;
- Stage III Ovarian Cancer AJCC v8;
- Stage III Primary Peritoneal Cancer AJCC v8;
- Stage IV Fallopian Tube Cancer AJCC v8;
- Stage IV Ovarian Cancer AJCC v8;
- Stage IV Primary Peritoneal Cancer AJCC v8;
- Stage II Fallopian Tube Cancer AJCC v8;
- Stage II Ovarian Cancer AJCC v8;
- Stage II Primary Peritoneal Cancer AJCC v8;
- Low Grade Fallopian Tube Serous Adenocarcinoma;
- Ovarian Low Grade Serous Adenocarcinoma;
- Primary Peritoneal Low Grade Serous Adenocarcinoma
-
Yvette Drew, MDSeen in:
- British Columbia, Vancouver, BC Cancer Center
Trials:- NCT05483933 (Principal Investigator)
Clinical Trials on Fallopian Tube Cancer
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedStage IIA Fallopian Tube Cancer | Stage IIA Ovarian Cancer | Stage IIB Fallopian Tube Cancer | Stage IIB Ovarian Cancer | Stage IIC Fallopian Tube Cancer | Stage IIC Ovarian Cancer | Stage IIIA Fallopian Tube Cancer | Stage IIIA Ovarian Cancer | Stage IIIA Primary Peritoneal Cancer | Stage IIIB Fallopian... and other conditionsUnited States
-
OncoMed Pharmaceuticals, Inc.CompletedCancer Ovaries | Cancer Peritoneal | Cancer, Fallopian TubeUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...Istituto Di Ricerche Farmacologiche Mario Negri; Foundation MedicineRecruitingAdvanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube CancerItaly
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)WithdrawnRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Stage IIA Fallopian Tube Cancer | Stage IIA Ovarian Cancer | Stage IIB Fallopian Tube Cancer | Stage IIB Ovarian Cancer | Stage IIC Fallopian Tube Cancer | Stage IIC Ovarian Cancer | Stage IIIA Fallopian... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.CompletedOvarian Cancer | Peritoneal Cancer | Fallopian Tubes CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)Active, not recruitingStage I Ovarian Cancer AJCC v6 and v7 | Stage IA Fallopian Tube Cancer AJCC v6 and v7 | Stage IB Fallopian Tube Cancer AJCC v6 and v7 | Stage IC Fallopian Tube Cancer AJCC v6 and v7 | Stage II Ovarian Cancer AJCC v6 and v7 | Stage IIA Fallopian Tube Cancer AJCC v6 and v7 | Stage IIB Fallopian... and other conditionsUnited States
-
Centre Jean PerrinCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerFrance
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); Sanofi Pasteur, a Sanofi CompanyCompletedStage IV Ovarian Epithelial Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Stage IV Primary Peritoneal Cavity Cancer | Recurrent Fallopian Tube Cancer | Stage IIA Fallopian Tube Cancer | Stage IIB Fallopian Tube Cancer | Stage IIC Fallopian Tube Cancer | Stage... and other conditionsUnited States
-
AGO Study GroupCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerGermany
-
European Organisation for Research and Treatment...CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerFrance, Canada, Spain, Norway, Belgium, Netherlands, United Kingdom, Portugal, Austria, Denmark, Ireland, Sweden, Italy, Argentina, Germany